Giuseppa Maltese
Milan, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Phase I Study of Rucaparib in Combination with Bevacizumab in Ovarian Cancer Patients: Maximum Tolerated Dose and Pharmacokinetic Profile.
Journal: Targeted oncology
Published: November 13, 2020
Olaparib as maintenance therapy in patients with BRCA 1-2 mutated recurrent platinum sensitive ovarian cancer: Real world data and post progression outcome.
Journal: Gynecologic oncology
Published: August 05, 2019
The MITO CERV-2 trial: A randomized phase II study of cetuximab plus carboplatin and paclitaxel, in advanced or recurrent cervical cancer.
Journal: Gynecologic oncology
Published: March 05, 2019
RECIST 1.1 criteria predict recurrence-free survival in advanced ovarian cancer submitted to neoadjuvant chemotherapy.
Journal: European journal of obstetrics, gynecology, and reproductive biology
Published: March 01, 2019
Surgical Efforts Might Mitigate Difference in Response to Neoadjuvant Chemotherapy in Stage IIIC-IV Unresectable Ovarian Cancer: A Case-Control Multi-institutional Study.
Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: October 31, 2018
Capecitabine in patients with platinum-pretreated advanced or recurrent cervical carcinoma: a retrospective study.
Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: October 09, 2018
Spotlight on olaparib in the treatment of BRCA-mutated ovarian cancer: design, development and place in therapy.
Journal: Drug design, development and therapy
Published: June 09, 2018
Rucaparib: a new treatment option for ovarian cancer.
Journal: Expert opinion on pharmacotherapy
Published: April 20, 2018
Pegylated liposomal doxorubicin re-challenge in patients with ovarian cancer relapse: a multicenter retrospective study.
Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: April 06, 2018
The Impact of Number of Cycles of Neoadjuvant Chemotherapy on Survival of Patients Undergoing Interval Debulking Surgery for Stage IIIC-IV Unresectable Ovarian Cancer: Results From a Multi-Institutional Study.
Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: October 25, 2017
Last Updated: 09/26/2026